Daktacort

How to order Daktacort

1. Find the drug you need on our site.
2. Pick a clinic. See the price.
3. Fill in a short health form.
4. A doctor reads your form.
5. If it is safe for you, they say yes.
6. Your order ships fast to your door.
7. It comes in a plain, sealed box.

Why use us? We compare UK clinics. We show you the price and how fast they ship. We do not sell drugs. We just help you find the best one for you.

Is it safe? Yes. All our clinics are UK-based. A real doctor reads each form. They will not sell to you if it is not safe for you.

Daktacort on Prescriptsy

Daktacort is described on Prescriptsy as independent product information.

Here you can understand how online consultation works, what medical checks partner clinics carry out, and which factors matter when comparing providers.

We do not sell medicines directly, but help users compare licensed healthcare partners on price, delivery speed, service quality, and overall trustworthiness.

Daktacort cream is a topical combination medicine containing hydrocortisone 1% (a mild corticosteroid) and miconazole nitrate 2% (a broad-spectrum antifungal).

It is licensed in the United Kingdom for the treatment of inflamed dermatoses where fungal or candidal infection is present or suspected, including candidal intertrigo, infected eczema, and candidal nappy rash.

Daktacort addresses both the infective cause and the inflammatory symptoms in a single preparation, making it a practical first-line choice for conditions where the clinical picture involves both elements.

Fungal and yeast skin infections are extremely common in the UK, and many present with significant inflammation that causes discomfort and distress.

Candidal intertrigo in skin folds, nappy rash complicated by Candida albicans, athlete's foot with secondary inflammation, and eczema colonised by dermatophytes all benefit from the dual-action approach that Daktacort provides.

This page offers a comprehensive clinical overview of how Daktacort works, correct application technique, treatment duration, side effects, safety warnings, and how to obtain a prescription in the United Kingdom.

Important safety information about Daktacort

Before reading further, note the following essential safety points. Daktacort is a prescription-only medicine (POM) in the UK for most indications and should be used under medical guidance.

• Do not use Daktacort on viral skin infections (cold sores, chickenpox, shingles), untreated bacterial infections (impetigo), rosacea, acne, or perioral dermatitis.
• Avoid prolonged use on the face (maximum 5 to 7 days) and in skin folds where absorption is increased.
• In children and infants, use the minimum amount for the shortest effective time. Nappies can act as occlusive dressings, increasing steroid absorption.
• If you take warfarin, tell your doctor before using Daktacort, as miconazole can increase anticoagulant effect even when applied topically.
• Seek medical advice if the condition does not improve within 7 days or if it worsens.

Understanding fungal skin infections with inflammation

The skin is a complex organ with its own microbiome, including yeasts such as Candida albicans and dermatophyte fungi such as Trichophyton rubrum.

Under normal conditions, these organisms live harmlessly on the skin surface, kept in check by the intact skin barrier, local immune defences, and competing bacterial flora.

When conditions change, these organisms can proliferate and invade the outer layers of the skin, triggering an inflammatory response.

Warm, moist environments favour fungal growth.

Skin folds (under the breasts, in the groin, between the buttocks, in the axillae) are particularly susceptible because of heat, moisture, and friction.

In infants, the nappy area creates an ideal environment for candidal overgrowth. Occlusive footwear promotes dermatophyte infection of the feet.

Immunocompromise, diabetes, obesity, antibiotic use, and corticosteroid therapy can all increase susceptibility to fungal skin infection.

When a fungal infection triggers an inflammatory response, the skin becomes red, itchy, swollen, and sometimes painful.

In candidal infections, satellite pustules and a glazed erythematous base are characteristic. In dermatophyte infections, a spreading ring with a raised, scaly border is typical.

The inflammation is the body's attempt to fight the infection but often causes as much discomfort as the infection itself, creating a clinical picture that requires both antifungal treatment and anti-inflammatory control.

How Daktacort works: mechanism of action

Daktacort combines two active ingredients that address the two components of inflamed fungal skin disease.

Miconazole nitrate 2%: antifungal action

Miconazole belongs to the imidazole class of antifungals. It works by inhibiting the enzyme lanosterol 14-alpha-demethylase, a cytochrome P450 enzyme essential for the synthesis of ergosterol.

Ergosterol is a critical structural component of fungal cell membranes, analogous to cholesterol in human cell membranes.

When ergosterol synthesis is blocked, the fungal cell membrane becomes unstable and permeable, leading to leakage of intracellular contents and cell death.

Miconazole has a broad spectrum of activity against dermatophytes (including Trichophyton rubrum, T. mentagrophytes, Epidermophyton floccosum, and Microsporum species), Candida species (including C.

albicans), and certain Gram-positive bacteria (including some strains of Staphylococcus and Streptococcus).

This antibacterial activity can be beneficial in mixed infections where bacterial superinfection complicates a primary fungal dermatosis.

Hydrocortisone 1%: anti-inflammatory action

Hydrocortisone is classified as a mild (Group I) topical corticosteroid in the UK potency ranking system.

It acts by binding to intracellular glucocorticoid receptors and modulating gene transcription, resulting in reduced production of pro-inflammatory cytokines (including interleukin-1, interleukin-6, and tumour necrosis factor-alpha), decreased synthesis of prostaglandins and leukotrienes, reduced capillary permeability, and inhibition of leucocyte migration to the inflamed site.

The clinical result is rapid reduction in redness, itching, swelling, and discomfort.

As a mild corticosteroid, hydrocortisone 1% carries a low risk of local side effects when used appropriately, making it suitable for use in sensitive areas such as the face, skin folds, and the nappy area in infants.

However, these same areas have thinner skin and greater absorption, so duration of use must still be limited.

Conditions treated with Daktacort

Candidal intertrigo

Intertrigo is inflammation of skin folds caused by friction, moisture, and heat.

When Candida albicans colonises inflamed intertriginous skin, the result is candidal intertrigo, characterised by bright red, moist, macerated skin with satellite pustules beyond the main border.

Common sites include the submammary folds, groin, axillae, intergluteal cleft, and abdominal folds. Daktacort is an established first-line treatment, targeting both the yeast infection and the inflammatory component.

Candidal nappy rash

Nappy rash affects the majority of infants at some point.

When Candida colonises irritant nappy dermatitis, the rash typically becomes more intense, with a bright red, glazed appearance and satellite lesions.

Simple barrier creams alone are insufficient once candidal infection is established. Daktacort provides antifungal treatment alongside gentle anti-inflammatory control, usually producing visible improvement within a few days.

Infected eczema

Eczematous skin has a disrupted barrier and altered microbial colonisation. Fungal colonisation of eczema, particularly in moist flexural areas, can perpetuate the inflammatory cycle.

Daktacort can be used for short courses to address both the inflammatory eczema and the fungal component, though it is important that the underlying eczema management plan is reviewed alongside acute treatment.

Inflammatory tinea

Dermatophyte infections (tinea) occasionally present with significant inflammation, particularly tinea cruris (groin) and tinea pedis (feet) in acute flares.

In these cases, a short initial course of combined antifungal-corticosteroid therapy can reduce symptoms rapidly, with continuation of antifungal monotherapy once the inflammation has settled.

This approach should be guided by clinical judgement, as corticosteroids can mask the clinical signs of infection if used inappropriately or for too long.

How to apply Daktacort correctly

Wash and gently dry the affected area before application. Apply a thin layer of Daktacort cream to the affected skin and rub gently until absorbed.

Use the fingertip unit (FTU) method to gauge the appropriate amount: one FTU (the amount of cream squeezed from a standard tube from the tip of an adult index finger to the first crease, approximately 0.5 g) is sufficient to cover an area of skin equal to two flat adult palms.

Apply twice daily, morning and evening, unless your doctor advises otherwise.

For nappy rash, apply at each nappy change (typically 2 to 3 times daily), ensuring the skin is clean and dry first.

Do not apply under airtight dressings unless specifically instructed by your prescriber.

Treatment duration should be as short as clinically necessary. Most conditions respond within 2 to 4 weeks. On the face, limit use to 5 to 7 days.

For nappy rash, reassess if no improvement is seen after 7 days.

Once the inflammation has settled and only fungal infection remains, your doctor may recommend switching to a plain antifungal cream (such as miconazole 2% alone) to complete the course.

Side effects of Daktacort

Common side effects

Mild burning, stinging, or itching at the application site is common, particularly during the first few days. This usually subsides with continued use and is not a reason to stop treatment unless it becomes severe or persistent.

Effects of prolonged or excessive use

Overuse of Daktacort, particularly under occlusion, on the face, or in skin folds, can lead to local corticosteroid effects including skin thinning, stretch marks, visible small blood vessels, increased fine hair growth, lightening of skin colour, and perioral dermatitis.

These effects are largely reversible once the cream is discontinued, though striae may be permanent.

In infants and young children, systemic absorption of hydrocortisone is proportionally greater. Prolonged use may suppress the hypothalamic-pituitary-adrenal axis, with potential effects on growth and adrenal function.

This is why paediatric use should be limited to the minimum effective duration under medical supervision.

Allergic reactions

Rarely, contact sensitivity to miconazole or hydrocortisone may develop, manifesting as worsening redness, vesiculation, or oozing at the application site.

If the condition deteriorates during treatment, stop using Daktacort and seek medical advice. Patch testing may be recommended to identify the responsible allergen.

When to seek medical advice

Contact your GP or NHS 111 if the condition does not improve after 7 days, if it worsens during treatment, or if you notice signs of skin thinning or stretch marks.

Seek urgent care if you develop a widespread skin reaction, facial swelling, or difficulty breathing.

Report suspected adverse reactions to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk .

Warnings and precautions

Conditions where Daktacort must not be used

Do not apply Daktacort to viral skin infections (herpes simplex, varicella, herpes zoster), untreated bacterial infections (impetigo), tuberculous skin lesions, rosacea, acne vulgaris, or perioral dermatitis.

Using a corticosteroid on these conditions can cause significant worsening. Do not apply to the eyes or mucous membranes.

Caution areas: face, folds, and children

The face, skin folds, and the nappy area have thinner skin and greater corticosteroid absorption.

Use Daktacort for the minimum effective duration in these areas: no more than 5 to 7 days on the face, and no more than 7 days in infants with nappy rash unless medically reviewed.

Nappies and tight clothing can act as occlusive coverings.

Warfarin interaction

Miconazole inhibits CYP2C9, the enzyme responsible for warfarin metabolism. Even topical application can produce sufficient systemic absorption to increase INR and raise bleeding risk.

If you take warfarin or another coumarin anticoagulant, inform your prescriber before starting Daktacort. INR monitoring should be intensified during and shortly after treatment.

Pregnancy and breastfeeding

Use Daktacort with caution during pregnancy. Apply to the smallest possible area for the shortest duration, and only if clinically necessary.

There is limited evidence of harm from brief, localised use of mild topical corticosteroids during pregnancy, but prolonged or extensive application should be avoided.

Do not apply Daktacort to the nipple area during breastfeeding.

How to get a Daktacort prescription in the UK

Daktacort is a prescription-only medicine for most indications. Your GP can prescribe it following a clinical assessment of the skin condition.

A pharmacist may be able to supply Daktacort HC Cream for adults and children over 10 for certain specific indications (candidal intertrigo, athlete's foot) without a prescription, following a pharmacist consultation.

For infants, children under 10, facial use, or other indications, a prescription is required.

The standard NHS prescription charge in England is currently 9.90 pounds per item; prescriptions are free in Scotland, Wales, and Northern Ireland.

When to seek medical advice

See your GP if a fungal skin infection does not respond to Daktacort within 7 to 14 days, if it recurs frequently, or if you are unsure of the diagnosis.

Recurrent candidal infections may warrant investigation for underlying conditions such as diabetes or immunodeficiency.

For infants, seek medical advice if nappy rash does not improve within 7 days or if the infant appears unwell.

Report any adverse reactions via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk .

Sources

• Daktacort Cream, Summary of Product Characteristics (EMC)
• Hydrocortisone with miconazole, British National Formulary (BNF)
• NICE CKS: Candida, skin
• Thrush, NHS
• British Association of Dermatologists, Fungal Infections
• MHRA Yellow Card Scheme